SOBRsafe Inc. (NASDAQ: SOBR) Announces Partnership with Navix Health Aimed at Enhancing Patient Care and Outcomes
- SOBRsafe’s alcohol detection technology can improve behavioral outcomes and help save lives
- Navix Health, a leading provider of innovative behavioral healthcare support technologies, has chosen SOBRsafe as its exclusive alcohol data partner, integrating SOBRsafe’s transdermal detection solutions into Navix Hub(TM)
- SOBRsafe’s products include SOBRsafe(TM), SOBRcheck(TM), and SOBRsure(TM)
SOBRsafe (NASDAQ: SOBR), a provider of advanced transdermal alcohol detection technology, recently announced that Navix Health, a leading provider of behavioral healthcare support technologies, has chosen SOBRsafe as its exclusive alcohol data partner, integrating the company’s transdermal detection solutions into Navix Hub(TM). With the integration of SOBRsafe into Navix Hub, customers can augment current operations with touch-based alcohol monitoring, with the results flowing directly into their client records platform. The collaboration marks a significant milestone in advancing digital health and enhancing patient-centric care (https://nnw.fm/tf3uv ).
Dave Gandini, Chairman and CEO of SOBRsafe, said the company’s goal is to empower positive outcomes. “In this, we are wholly aligned with Navix Health, and we believe the integration with Navix Hub(TM) positions both our organizations to create maximum benefit through actionable alcohol intelligence. We are excited to partner with Navix Health, and we look forward to providing value to their customers industry-wide,” Gandini added.
SOBRsafe’s alcohol detection technology can improve workplace safety and provide advanced screening and monitoring solutions for the behavioral health industry. The company has developed a patent-pending alcohol detection device called SOBRcheck(TM) to detect alcohol in humans with just a single touch of the finger. SOBRsafe’s next-generation transdermal technology detects and instantaneously reports the presence of alcohol through the user’s skin. No breath, blood, or urine samples are required – making it a hygienic alternative to traditional breathalyzers.
SOBRsafe’s technology is integrated within the company’s robust and scalable data platform, producing statistical and measurable user and business data. The company’s products include:
SOBRsafe(TM) – The company’s patent-pending platform for non-invasive alcohol detection, with real-time reporting and historical data aggregation. SOBRsafe is a solution that has broad potential applications across all industries, but with an immediate focus in behavioral health and justice.
SOBRcheck(TM) – The company’s stationary identification and alcohol detection product provides quick, specific, point-of-care screening. The device verifies user identity and determines the presence or absence of alcohol, providing administrators with immediate, actionable results, delivered securely.
SOBRsure(TM) – The company’s transdermal, alcohol-detecting wearable band that provides continuous monitoring, discreetly detecting and instantaneously reporting the presence or absence of alcohol by the band wearer. SOBRsure also provides app-based alcohol detection alerts, pinpoint location tracking and band-removal notifications.
SOBRcheck and SOBRsure revenue models consist of flexible structures ensuring monthly recurring revenue. The SOBRsafe products have a powerful backend data platform, providing humane, passive and connected alcohol detection for the behavioral health and justice markets, and for licensing, integration and consumers.
The partnership between Navix Health and SOBRsafe combines expertise to offer comprehensive digital health solutions to address the evolving needs of patients, healthcare providers and stakeholders in the healthcare industry. By integrating SOBRsafe’s advanced alcohol monitoring technology with Navix Health’s robust EMR, both companies aim to enhance patient care, increase compliance and promote better health outcomes.
For more information, visit the company’s website at www.SOBRsafe.com.
NOTE TO INVESTORS: The latest news and updates relating to SOBR are available in the company’s newsroom at https://nnw.fm/SOBR
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- SOBRsafe’s alcohol detection technology can improve behavioral outcomes and help save lives
- Navix Health, a leading provider of innovative behavioral healthcare support technologies, has chosen SOBRsafe as its exclusive alcohol data partner, integrating SOBRsafe’s transdermal detection solutions into Navix Hub(TM)
- SOBRsafe’s products include SOBRsafe(TM), SOBRcheck(TM), and SOBRsure(TM)
SOBRsafe (NASDAQ: SOBR), a provider of advanced transdermal alcohol detection technology, recently announced that Navix Health, a leading provider of behavioral healthcare support technologies, has chosen SOBRsafe as its exclusive alcohol data partner, integrating the company’s transdermal detection solutions into Navix Hub(TM). With the integration of SOBRsafe into Navix Hub, customers can augment current operations with touch-based alcohol monitoring, with the results flowing directly into their client records platform. The collaboration marks a significant milestone in advancing digital health and enhancing patient-centric care (https://nnw.fm/tf3uv ).
Dave Gandini, Chairman and CEO of SOBRsafe, said the company’s goal is to empower positive outcomes. “In this, we are wholly aligned with Navix Health, and we believe the integration with Navix Hub(TM) positions both our organizations to create maximum benefit through actionable alcohol intelligence. We are excited to partner with Navix Health, and we look forward to providing value to their customers industry-wide,” Gandini added.
SOBRsafe’s alcohol detection technology can improve workplace safety and provide advanced screening and monitoring solutions for the behavioral health industry. The company has developed a patent-pending alcohol detection device called SOBRcheck(TM) to detect alcohol in humans with just a single touch of the finger. SOBRsafe’s next-generation transdermal technology detects and instantaneously reports the presence of alcohol through the user’s skin. No breath, blood, or urine samples are required – making it a hygienic alternative to traditional breathalyzers.
SOBRsafe’s technology is integrated within the company’s robust and scalable data platform, producing statistical and measurable user and business data. The company’s products include:
SOBRsafe(TM) – The company’s patent-pending platform for non-invasive alcohol detection, with real-time reporting and historical data aggregation. SOBRsafe is a solution that has broad potential applications across all industries, but with an immediate focus in behavioral health and justice.
SOBRcheck(TM) – The company’s stationary identification and alcohol detection product provides quick, specific, point-of-care screening. The device verifies user identity and determines the presence or absence of alcohol, providing administrators with immediate, actionable results, delivered securely.
SOBRsure(TM) – The company’s transdermal, alcohol-detecting wearable band that provides continuous monitoring, discreetly detecting and instantaneously reporting the presence or absence of alcohol by the band wearer. SOBRsure also provides app-based alcohol detection alerts, pinpoint location tracking and band-removal notifications.
SOBRcheck and SOBRsure revenue models consist of flexible structures ensuring monthly recurring revenue. The SOBRsafe products have a powerful backend data platform, providing humane, passive and connected alcohol detection for the behavioral health and justice markets, and for licensing, integration and consumers.
The partnership between Navix Health and SOBRsafe combines expertise to offer comprehensive digital health solutions to address the evolving needs of patients, healthcare providers and stakeholders in the healthcare industry. By integrating SOBRsafe’s advanced alcohol monitoring technology with Navix Health’s robust EMR, both companies aim to enhance patient care, increase compliance and promote better health outcomes.
For more information, visit the company’s website at www.SOBRsafe.com.
NOTE TO INVESTORS: The latest news and updates relating to SOBR are available in the company’s newsroom at https://nnw.fm/SOBR
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
1
